增加了I型肺干扰素的反应,并降低了COVID-19疾病的严重程度:一个开放标签随机临床试验的结果
René Traksel1, Jasper Broen1, Arjen van Henten2
1Regional Rheumatology Center, Maxima Medical Center Eindhoven, The Netherlands.
PloS one
|February 2, 2026
概括
口服补充剂没有降低住院COVID-19患者的死亡率或重症监护室 (ICU) 的入院率. 然而,在探索性分析中,治疗与更短的ICU停留和增强的抗病毒反应有关.
科学领域:
- * 传染病研究 传染病研究
- * 临床药理学 临床药理学
- * 免疫学 免疫学
背景情况:
- *严重的COVID-19需要住院治疗,并可能导致严重疾病.
- * 住院COVID-19患者的标准护理可能受益于辅助疗法.
- *在免疫功能和病毒反应中的作用是人们感兴趣的一个领域.
研究的目的:
- * 评估12.5毫克口服作为标准护理的辅助剂在住院COVID-19患者的死亡率和临床恶化降低中的疗效.
- * 探索口服对疾病进展和免疫反应的潜在益处.
主要方法:
- * 一个单中心,随机临床试验 (EudraCT 2020-001852-16) 涉及重症COVID-19住院患者.
- *患者随机分配,接受12.5毫克口服8天或仅接受标准治疗.
- *主要终点包括疾病恶化 (转移到ICU或死亡);还进行了探索性分析和体外验证.
主要成果:
- * 和对照组 (141名参与者分析) 之间死亡率或ICU转移没有显著差异.
- * 探索性分析表明,接受口服的患者在ICU停留时间显著缩短 (p=0.016).
- *体外研究表明,在给药后,肺细胞I型干扰素反应增加.
结论:
- *12.5毫克口服并没有降低住院COVID-19患者的死亡率或ICU入院率.
- *补充剂可能通过I型干扰素途径增强抗病毒免疫力,可能导致更短的ICU停留时间.
- *需要进一步的研究来阐明在IFN-I介导的抗病毒免疫力中的作用.
相关概念视频
01:16Clinical Trials
10.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.5K
01:11Clinical Trials: Overview
5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
01:12Statistical Software for Data Analysis and Clinical Trials
1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:27Decreasing Function
290
A decreasing function describes a relationship where the output consistently declines as the input increases. This means that for any two input values, if one is greater than the other, the corresponding output is smaller. Mathematically, a function f is decreasing on an interval I if for every x1 < x2 in I, f (x1) > f (x2). This type of behavior is visually identified on a graph that slopes downward from left to right.The nature of a function can be analyzed by calculating...
290
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K